IE51034B1 - A pharmaceutical formulation of a vinca dimer - Google Patents

A pharmaceutical formulation of a vinca dimer

Info

Publication number
IE51034B1
IE51034B1 IE609/81A IE60981A IE51034B1 IE 51034 B1 IE51034 B1 IE 51034B1 IE 609/81 A IE609/81 A IE 609/81A IE 60981 A IE60981 A IE 60981A IE 51034 B1 IE51034 B1 IE 51034B1
Authority
IE
Ireland
Prior art keywords
formula
compound
vlb
dimer
pharmaceutically
Prior art date
Application number
IE609/81A
Other languages
English (en)
Other versions
IE810609L (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IE810609L publication Critical patent/IE810609L/xx
Publication of IE51034B1 publication Critical patent/IE51034B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IE609/81A 1980-03-20 1981-03-19 A pharmaceutical formulation of a vinca dimer IE51034B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/132,246 US4357334A (en) 1980-03-20 1980-03-20 Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms

Publications (2)

Publication Number Publication Date
IE810609L IE810609L (en) 1981-09-20
IE51034B1 true IE51034B1 (en) 1986-09-17

Family

ID=22453135

Family Applications (1)

Application Number Title Priority Date Filing Date
IE609/81A IE51034B1 (en) 1980-03-20 1981-03-19 A pharmaceutical formulation of a vinca dimer

Country Status (28)

Country Link
US (1) US4357334A (OSRAM)
EP (1) EP0036762B1 (OSRAM)
JP (1) JPS56145293A (OSRAM)
KR (1) KR840002146B1 (OSRAM)
AR (1) AR228863A1 (OSRAM)
AT (1) ATE9761T1 (OSRAM)
AU (1) AU539564B2 (OSRAM)
BG (1) BG36200A3 (OSRAM)
CA (1) CA1159055A (OSRAM)
DD (1) DD157558A5 (OSRAM)
DE (1) DE3166544D1 (OSRAM)
DK (1) DK124281A (OSRAM)
EG (1) EG15247A (OSRAM)
ES (2) ES500536A0 (OSRAM)
FI (1) FI810856A7 (OSRAM)
GB (1) GB2072184B (OSRAM)
GR (1) GR73870B (OSRAM)
HU (1) HU185247B (OSRAM)
IE (1) IE51034B1 (OSRAM)
IL (1) IL62378A (OSRAM)
NZ (1) NZ196511A (OSRAM)
PH (1) PH16213A (OSRAM)
PL (1) PL230226A1 (OSRAM)
PT (1) PT72695B (OSRAM)
RO (2) RO85813B (OSRAM)
SU (2) SU1017172A3 (OSRAM)
YU (1) YU66281A (OSRAM)
ZA (1) ZA811733B (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE64396T1 (de) * 1983-04-29 1991-06-15 Omnichem Sa Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
HUT76925A (hu) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bisz-indol-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204004A1 (es) 1973-04-02 1975-11-12 Lilly Co Eli Procedimientos para preparar derivados de vinblastina leurosidina y leurocristina
IL48685A (en) 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (OSRAM) 1976-09-08 1982-07-07 Lilly Co Eli
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates
US4160767A (en) * 1976-12-06 1979-07-10 Eli Lilly And Company Vinca alkaloid intermediates
US4191688A (en) * 1977-08-08 1980-03-04 Eli Lilly And Company Amides of leurosine, leuroformine, desacetylleurosine and desacetylleuroformine
US4203898A (en) * 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids

Also Published As

Publication number Publication date
IE810609L (en) 1981-09-20
ES8206538A1 (es) 1982-08-16
IL62378A (en) 1984-03-30
RO82171B (ro) 1983-06-30
EP0036762A2 (en) 1981-09-30
SU1017172A3 (ru) 1983-05-07
SU1200851A3 (ru) 1985-12-23
EG15247A (en) 1986-03-31
EP0036762A3 (en) 1981-10-07
AU539564B2 (en) 1984-10-04
PH16213A (en) 1983-08-05
DK124281A (da) 1981-09-21
RO85813A (ro) 1984-11-25
DE3166544D1 (en) 1984-11-15
PL230226A1 (OSRAM) 1982-03-15
GB2072184A (en) 1981-09-30
RO82171A (ro) 1983-07-07
ZA811733B (en) 1982-10-27
PT72695B (en) 1982-03-24
DD157558A5 (de) 1982-11-17
CA1159055A (en) 1983-12-20
ATE9761T1 (de) 1984-10-15
AU6858181A (en) 1981-09-24
EP0036762B1 (en) 1984-10-10
GB2072184B (en) 1984-01-11
KR840002146B1 (ko) 1984-11-23
RO85813B (ro) 1984-11-30
AR228863A1 (es) 1983-04-29
PT72695A (en) 1981-04-01
NZ196511A (en) 1983-09-30
IL62378A0 (en) 1981-05-20
ES8302009A1 (es) 1982-12-16
ES509581A0 (es) 1982-12-16
GR73870B (OSRAM) 1984-05-09
HU185247B (en) 1984-12-28
KR830005248A (ko) 1983-08-03
ES500536A0 (es) 1982-08-16
BG36200A3 (bg) 1984-09-14
FI810856L (fi) 1981-09-21
US4357334A (en) 1982-11-02
FI810856A7 (fi) 1981-09-21
JPS56145293A (en) 1981-11-11
YU66281A (en) 1983-10-31

Similar Documents

Publication Publication Date Title
NZ235306A (en) Thienylacetic acid esters and pharmaceutical compositions
Jenkins et al. Synthesis and evaluation of. alpha.-[[(2-haloethyl) amino] methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of. alpha.-[(1-aziridinyl) methyl]-2-nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxins
Ciotti et al. The antileukemic action of two thiadiazole derivatives
RU2300535C2 (ru) Полиморфная форма кристаллического гидрохлорида иринотекана, способ ее получения и фармацевтическая композиция на ее основе
Aristoff et al. Synthesis and biochemical evaluation of the CBI-PDE-I-dimer, a benzannelated analog of (+)-CC-1065 that also produces delayed toxicity in mice
EP0036762B1 (en) A pharmaceutical formulation of a vinca dimer
US4479957A (en) Use of vindesine in treating acute lymphatic leukemia and _other susceptible neoplasms
CA1318595C (en) 2-alkoxy-n-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides
WO2007104214A1 (en) Camptothecin derivatives and their use
JPH01228965A (ja) 縮合キノリン系化合物及び縮合アクリジン系化合物、それらの製造法ならびにそれらの化合物を有効成分とする抗癌剤
US4322351A (en) Antineoplastic 4'-formylamino and 4'-acetylamino VLB, and derivatives thereof
US3954773A (en) 4-Desacetoxyvinblastine
CA1315691C (en) Therapeutic agents containing enantiomers of propafenone
HU180724B (en) Process for producing vinblastine-3-spiro-5-comma above-comma above-oxazolidine-2-comma above-comma above,4-comma above-comma above-dione
EP0147152B1 (en) Improvements in or relating to novel salts of dimeric indole-dihydroindole alkaloids
IE45213B1 (en) Penicillin compositions
US10407437B2 (en) Camptothecin derivatives and uses thereof
US3627886A (en) Methods of solubilizing coumermycin employing urea, dimethylacetamide or mixtures thereof
US3885040A (en) Methods and benzamide compositions for producing hypotensive activity
EP0626383B1 (en) Palau'amine: a pharmacologically active compound from a sponge
WO1990004396A1 (en) Antiemesis ergoline derivatives
KR20000075651A (ko) 전립선 암의 치료 또는 예방을 위한 조성물
US4362664A (en) Vinblastine oxazolidinedione disulfides and related compounds
US4195022A (en) 4-Desacetoxy-4α-hydroxyvinblastine and related compounds
WO1990015811A1 (fr) Spicamycine x et son utilisation